Ignite Creation Date:
2024-05-06 @ 6:30 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05687825
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2023-01-08
Brief Title:
Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula
Sponsor:
South Valley University
Organization:
South Valley University
Study Overview
Official Title:
Operative Risk Factors for Clinically Relevant Postoperative Pancreatic Fistula After Pancreaticoduodenectomy A Prospective Multicenter Cohort Study
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
For periampullary and pancreatic head disorders pancreaticoduodenectomy PD is the standard treatment However PD is technically demanding and has high morbidity and mortality rates The most significant and life-threatening complication of PD is postoperative pancreatic fistula POPF with reported rates of 5 to 70 for total POPF and 10 to 45 for clinically relevant CR-POPF Operative risk variables for CR-POPF after PD were investigated in this study
Detailed Description:
For periampullary and pancreatic head disorders pancreaticoduodenectomy PD is the standard treatment However PD is technically demanding and has high morbidity and mortality rates The most significant and life-threatening complication of PD is postoperative pancreatic fistula POPF with reported rates of 5 to 70 for total POPF and 10 to 45 for clinically relevant CR-POPF Operative risk variables for CR-POPF after PD were investigated in this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None